Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001879231-23-000002.pdf 0001879231-23-000002.rtf 0001879231-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001334549-23-000002.pdf 0001334549-23-000002.rtf 0001334549-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001943584-23-000002.pdf 0001943584-23-000002.rtf 0001943584-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001309653-23-000002.pdf 0001309653-23-000002.rtf 0001309653-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001741455-23-000002.pdf 0001741455-23-000002.rtf 0001741455-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001373585-23-000004.pdf 0001373585-23-000004.rtf 0001373585-23-000004.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001283301-23-000002.pdf 0001283301-23-000002.rtf 0001283301-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001192621-23-000002.pdf 0001192621-23-000002.rtf 0001192621-23-000002.xls
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001346432-23-000002.pdf 0001346432-23-000002.rtf 0001346432-23-000002.xls
Nov 10, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-22-000101.pdf 0000320017-22-000101.rtf 0000320017-22-000101.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA